Adam Brust

Adam Brust

Auto-generated profile, based on publicly available information

Adam Brust

Naval Biotechnology Group, Naval Medical Center Portsmouth , Portsmouth, VA 23708

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2023 in Military Medicine
Verified
Journal Article
Open access
PDF file
SHScott Hughey
Scott Hughey
JCJacob Cole
Jacob Cole
ABAdam Brust
Adam Brust
KCKyle Checchi
Kyle Checchi
JKJoshua Kotler
Joshua Kotler
ALAndrew Lin
Andrew Lin
The Falklands Campaign was fought a significant distance from the home base of the British Fleet. The planning and delivery of medical care during this campaign can provide significant lessons for strategic medical planning in other far spread geographic locations, including the Indo-Pacific region. Consideration of doctrine, including Role 1-4 facilities and the golden hour, may need to be reconsidered in light of changing scenarios. New concepts such as the “90-in-90” and “3-in-3” are also discussed as a framework for future planning in the U.S. Indo-Pacific Command area of responsibility.

2 July 2023 in BMJ Military Health
Verified
Journal Article
Closed access
PDF file
ABAdam Brust
Adam Brust
JCJ H Cole
J H Cole
JFJ Forte
J Forte
LML Mansfield
L Mansfield
SHS Hughey
S Hughey
ALA Lin
A Lin
Advances in technology have improved the ability for real-time communication and enhanced awareness of medically related information on the battlefield. A government off-the-shelf platform, Team Awareness Kit (TAK), may enhance the ability for battlefield healthcare delivery, evacuation, telecommunication, and medical command and control. Integration of TAK into existing medical infrastructure provides a global view of resources, patient movement and direct communication, significantly reducing the ‘fog of war’ as it relates to battlefield injury and evacuation. Rapid integration and adoption are technically feasible with minimal resource investment. This technology can be rapidly scaled for the increasingly interconnected world of healthcare delivery.

22 April 2021 in Military Medicine
Verified
Journal Article
Open access
PDF file
ABAdam K Brust
Adam K Brust
ALAmarateedha P LeCourt
Amarateedha P LeCourt
DBDerek A Benham
Derek A Benham
JGJonathan R Gower
Jonathan R Gower
SBSean D Birmingham
Sean D Birmingham
This case report is about a 51-year-old active duty male with JAK2 mutation and medical history significant for prehepatic portal hypertension from portal vein thrombus on lifelong anticoagulation with rivaroxaban, an oral factor Xa inhibitor, presenting with closed-loop small bowel obstruction requiring emergent laparotomy. We present this surgical case as it required emergent reversal of the oral factor Xa inhibitor with andexanet alfa.

22 May 2026 in Military Medicine
Verified
Journal Article
Closed access
JKJoshua Kotler
Joshua Kotler
SHScott Hughey
Scott Hughey
JCJacob Cole
Jacob Cole
ABAdam Brust
Adam Brust
KCKyle Checchi
Kyle Checchi
ALAndrew Lin
Andrew Lin
Introduction: Exsanguinating hemorrhage is a leading cause of preventable death in combat. The Joint Trauma System prioritizes cold-chain stored whole blood (CCSB) as the resuscitation fluid of choice for combat casualties. However, in distributed maritime operations (DMO) and future large-scale combat operations (LSCO), significant overwater distances, cold-chain requirements, and limited access to aviation assets complicate blood resupply. This is similarly true in complex disaster environments. Unmanned aerial systems (UAS) offer a potential solution by providing long-range, low-risk, and cost-efficient delivery of blood products. This study evaluates the feasibility of using a Group 3 UAS for endurance-distance blood resupply and related missions in a simulated operational military environment. Materials and Methods: Ten units of whole blood were collected from Sus domesticus and stored in citrated bags (CPD-A) at 1-6 °C. Three simulated missions were executed using a Skyways V2.6 UAS equipped with a climate-controlled payload bay: Endurance resupply mission of 10 units (4.66 kg) flown 313 miles at 500 feet AGL in a racetrack course; loiter and on-demand resupply mission of 3 units (1.31 kg) launched from a simulated Role 2 site, loitered 30 minutes, and delivered to a Role 1 site on command; logistics exchange mission of non-climate-controlled payload containing 8.2 kg of medical and surgical supplies flown 120 miles for simulated recovery and reuse. Flight telemetry, payload temperatures, and mission timelines were recorded. Operational forces (U.S. Navy Corpsmen, Nurses, and Physicians) conducted payload transfers after minimal training. Ambient temperature range was approximately 69-74 °F (20.5-23.3 °C) during the flight testing. Results: All flights were completed successfully. Whole blood remained within 1-6 °C throughout Flights 1 and 2. Flight 1 lasted 6 hours and covered 313 miles, consuming 17.49 lbs of JP-5 fuel. The UAV transitioned between VTOL and fixed-wing pusher modes without incident. Payload transfers at Role 1 and Role 2 sites were performed effectively by personnel following brief on-site instruction. Flight 3 confirmed the platform’s versatility in transporting non-temperature-sensitive medical equipment. Discussion: This study demonstrates the operational viability of Group 3 UAS to deliver CCSB over long distances exceeding previously documented UAV blood deliveries. It represents a significant increase in distance and capacity over current applications. The system offers significant advantages in contested environments by reducing risk to aircrew, operating on common fuel, and requiring minimal infrastructure. Payload-versus-distance tradeoffs remain the primary limitation, though offset by its low signature and fuel cost. Conclusions: Group 3 UAS can safely and effectively transport whole blood over operationally relevant distances (>300 miles), supporting LSCO, austere, and disaster environments. This approach has implications for future military doctrine, humanitarian assistance, and disaster relief. Further evaluation with human blood in real-world operational theaters is warranted.